Clinical Trial Update: Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome [EARLY_Phase 1]

View source ↗

Summary

This entry describes an early-phase 1 clinical trial evaluating a dry powder inhalation formulation of cyclosporine A in lung transplant recipients with bronchi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans Syndrome

Drugs mentioned

• Cyclosporine A (dry powder inhalation) (cyclosporine A)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Lung Transplantation, Bronchiolitis Obliterans | EARLY_Phase 1 | Status: UNKNOWN